Atara Biotherapeutics, Inc. - ATRA

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 21
Latest filed: Nov 10, 2026
Form Count
4 9
8-K 5
144 3
SCHEDULE 13D/A 2
SCHEDULE 13G/A 1
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Nov 10, 2026 8-K Nov 10, 2026 0001104659-26-125171 View
Sep 04, 2026 4 Sep 04, 2026 0000905148-26-004085 View
Aug 26, 2026 144 — 0000905148-26-003961 View
Aug 26, 2026 4 Aug 17, 2026 0000905148-26-003960 View
Aug 14, 2026 SCHEDULE 13G/A — 0000919574-26-005481 View
Aug 12, 2026 8-K Aug 12, 2026 0001193125-26-346857 View
Jul 24, 2026 4 Jul 22, 2026 0001104659-26-086733 View
Jul 24, 2026 SCHEDULE 13D/A — 0001104659-26-086728 View
Jun 26, 2026 8-K Jun 22, 2026 0001193125-26-285498 View
Jun 15, 2026 4 Jun 11, 2026 0000905148-26-002951 View
Jun 12, 2026 8-K Jun 09, 2026 0001213900-26-068264 View
Jun 11, 2026 4 Jun 09, 2026 0000905148-26-002919 View
Jun 11, 2026 4 Jun 09, 2026 0000905148-26-002920 View
Jun 11, 2026 4 Jun 09, 2026 0000905148-26-002921 View
May 20, 2026 4 May 18, 2026 0000905148-26-002570 View
May 20, 2026 4 May 18, 2026 0000905148-26-002571 View
May 18, 2026 144 — 0000905148-26-002506 View
May 18, 2026 144 — 0000905148-26-002507 View
May 14, 2026 SCHEDULE 13D/A — 0001104659-26-061506 View
May 13, 2026 SCHEDULE 13G — 0000919574-26-002914 View
May 12, 2026 8-K May 12, 2026 0001193125-26-219420 View